chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received Quadrivalent FLUMIST vaccine on 10/29/13. About 3-4 hours after she started with HA - on sides, not frontal - persisted HA despite of ibuprofen 400 mg given at time of initial symptom - woke up with the headache and had it through the night (brief sleep). Associated nausea, no vomiting. Had chills but no fever, no rash. HA resolved over night on 10/30/13.
pt exp rash (entire body);temp became lethargic-almost not arousal-t104 dx measles
Approximately two days after receiving the second dose of the Moderna COVID 19 vaccine, I developed severe acute abdominal pain, and was diagnosed with an acute appendicitis requiring emergency surgery. After the surgery was completed, I was told that, based on clinical presentation, along with onset of symptoms, the infection was more advanced than would have been expected. After surgery, I developed an ileus, a systemic infection, as well as an abscess which required a drain to be placed in my pelvis. I was inpatient in the hospital for 9 days due to these complications, and it is my belief that there is not only a correlation between receiving the second dose of the vaccine and developing this appendicitis, but a causation. Though I have not seen any reported cases, I know that there were at least seven reported cases of appendicitis with the Pfizer variant, and the technologies are very similar.
INCORRECT PRODUCT STORAGE; ADMINISTRATION OF EXPIRED VACCINE; ADMINISTRATION OF VACCINE EXPIRED DUE TO TEMPERATURE EXCURSION; This spontaneous report received from a pharmacist concerned a 25 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 1808986, and expiry: UNKNOWN) dose was not reported, administered on 14-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-JUN-2021, the patient experienced administration of vaccine expired due to temperature excursion. On 14-JUN-2021, the patient experienced administration of expired vaccine. On an unspecified date, the patient experienced incorrect product storage. The action taken with covid-19 vaccine was not applicable. The outcome of the administration of vaccine expired due to temperature excursion, incorrect product storage and administration of expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20210915852, 20210915731, 20210916228, 20210916312, 20210916300, 20210916455, 20210916553, 20210916520, 20210916129, 20210916415, 20210916498, 20210916584, 20210916715, 20210916768, 20210916697, 20210916658, 20210915719, 20210916465, 20210916910, 20210913164, 20210915623, 20210915646, 20210916965, 20210917160, 20210916849, 20210916907, 20210916959, 20210916808, 20210916811, 20210916965, 20210917074, 20210917163, 20210916401, 20210915748, 20210917500, 20210917515, 20210917603 and 20210917226.
10/23/2001 Shot #1, 10/25/01-extreme fatigue, headache, stomache ache, following day continuous, severe headache, sick, hot, dizzy. Doctor gave Gusifinise ?- took 1 pill, heart raced, face flushed, felt faint, and panicky. Next about Nov 12 or 13 was given Trixon. Nov 15 saw spots , floating along with severe headaches and had body tremors, stiff neck, tingling, numbness in arms, legs, and face and insomnia, sweating, hot flashes, weak, dizzy. Could stay up for only 3 hours a day, spent most of time in bed. Headache lasted 2 1/2 months. Pt is still dealing with fatigue, photo sensitivity, low blood pressure and sugar problems, vision problems, dizziness, weakness, forgetfulness. Pt had thyroid diabetes, and anxiety. All test taken were negative so are treating pt with anxiety and low blood sugar but they feel there is a underlying problem. Had all available test and didn't find a problem.
Temperature of 102F (axillary), redness and swelling at injection site of DTAP, 2 days, post vax.
Left arm/shoulder pain; Left arm/shoulder pain; Sternal pain; Fatigue; Headache; This is a spontaneous report from a contactable Other HCP (patient). A 33-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on left arm on 23Dec2020 16:00 at single dose for COVID-19 immunization. The patient medical history was not reported. There were no known allergies, no allergies to medications, food, or other products. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19, since the vaccination, the patient has not been tested for COVID-19. The patient experienced left arm/shoulder pain, headache, sternal pain, and fatigue on 24Dec2020. No treatment was received for the adverse events. Events outcome was not recovered.  Information on the lot/ batch number has been requested.
fever/His fever is 101.5; shaking; This is a spontaneous report from a contactable consumer or other non hcp from a Pfizer sponsored program Pfizer RxPathways (patient's mother). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 22Aug2021 as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Aug2021, the patient experienced fever/his fever is 101.5, shaking. The patient underwent lab tests and procedures which included body temperature: 101.5 on Aug2021. Therapeutic measures were taken as a result of fever/his fever is 101.5, shaking included Tylenol. Reporter stated that fever went up after Tylenol and was asking if patient can take advil. The outcome of the events was unknown.  Information about lot/batch number cannot be obtained. No further information expected.
Painful and stiff arm. Red rash. Warm to the touch. Swollen. Hard knot like feeling. About 4 inches long by 3 inches wide. This has been for about 56 hours so far with no change.
MODERNA VACCINE WAS ADMINISTERED TO A PATIENT AGE 11YEARS OLD. The vaccine is only indicated for individuals age 18 and above.
Shortness of breathe; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breathe) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL for an unknown indication.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced DYSPNOEA (Shortness of breathe). At the time of the report, DYSPNOEA (Shortness of breathe) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported. It was reported that patient experienced all the expected symptoms that is listed on the sheet.  Follow-up received 08-MAY-2021 date included no new information   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Follow-up received and does not contain any new information.
Lightheaded. Skin was clammy, convulsions started, Epi pen administered, she had tongue swelling, came around then eyes rolled back in head, nausea, blood pressure high.
No adverse event; Patient received Moderna bivalent booster 0.25mL dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient received Moderna bivalent booster 0.25mL dose) and NO ADVERSE EVENT (No adverse event) in a 50-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 030G22B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 13-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient received Moderna bivalent booster 0.25mL dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient received Moderna bivalent booster 0.25mL dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient received Moderna bivalent booster 0.25mL dose).    No concomitant medications were reported.  The reporter asked for guidance on how to proceed in the current scenario, enquiring would the patient need a new full dose or could the patient receive a half dose.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 17-Oct-2022: Live Follow-up received includes significant information : batch number was added.
I went to administer the vaccine, but the needle was not tightly screwed onto the syringe and the patient did not receive the dose (it came out of the syringe at the needle hub). I drew up another dose in a new syringe and administered that dose to the patient.
vertiginous; Light headedness; it has progressed to when she is walking and she feels like she will pass out.; This is a spontaneous report from a contactable Physician (patients father) via medical information team. A 27-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) via unknown route of administration on 09Apr2021 as a single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that the patient received the first dose of the Pfizer Covid 19 vaccine 3 weeks ago on 09Apr2021. Patient began experiencing vertiginous symptoms of light headedness and dizziness nocturnally when trying to lay down however it has progressed to when she is walking and she feels like she will pass out. The symptoms are persisting and she has not gotten significantly better. Reported stated that a search of her resources contain no information regarding his daughters symptoms being reported and that the PI for the vaccine contains no information about his daughters symptoms being reported. LAB-1457-7.0Revised: 06April2021. The outcome of the events were unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pain at injection site. < 24 hrs after administration of influenza vaccine, (L) thigh: hot, 2.3 cm induration, with surrounding erythema approx. 8 cm in diameter. No respiratory s/s. TYLENOL ice pack.
Slight dizziness 3 hrs. post-injection.   Low grade fever, 99.1, 5 hrs. post-injection.  Headache, fever, chills 15 hrs. post -injection. Loss of appetite and taste.  At the same time, had chills, and cold cyanotic fingers and hands.   Experienced lethargy, joint and body aches, and fever for next 12-15 hours.    Still experienced lack of appetite and loss of taste after 40 hours.     Have previously had Covid 19 in December 2020, as well as Pfizer Vaccine Dose 1 and 2.
2 days later, what felt like white canker sores began to develop in my mouth. It continues to get worse, painful, spreading in my mouth and I felt it in my throat. Around day 4 of symptoms, it felt painful in my gums as if they were a little swollen or had sores in them. Mostly on the right side on my tongue and right side of my mouth, with my tongue the worst. But it is all over my mouth and hurts swallowing. On day 5, I woke up with swollen lips and in so much pain (kept increasing every day) and I went to the immediate care. Doctor said mouth is all red with the white mouth sores that are painful. Diagnosis was ?mucositis? mouth sores and I got prescribed prednisone, lidocaine hydrochloride solution to rinse, and another medicine by mouth.   Concurrently from that Monday (2 days after shot): onset of flu-like symptoms: feverish for a day, extreme fatigue, headaches, body aches and pains.
Swollen Lymph nodes in left arm pit; Swollen Lymph nodes in left arm pit along with a lump; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 17Mar2021 at 15:30 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. The patient has not reported any other health issues. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient did not have a history of allergies to medications, food or other products. Concomitant medications were not reported. On 04Apr2021 at 05:00, the patient experienced swollen lymph nodes in left armpit along with a lump. It was unknown whether any therapeutic measures were taken as a result of the event. The event resulted in doctor or other healthcare professional office/clinic visit. Prior to the vaccination, the patient was not diagnosed with COVID-19. The clinical outcome of the event swollen lymph nodes in left armpit along with a lump was not recovered at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 09Apr2021 at 12:45 (at the age of 29-year-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Began shivering and feeling very cold despite room temp of 84.  Wife took temperature and it was 101.  This lasted for nearly 24 hours....took Tylenol 825 mg that evening and again the next morning.
Information has been received from an office manager via a field representative referring to a 60 year old male patient. Information about medical history, concurrent condition and concomitant medication was not reported. On 20-JUN-2015 the patient was vaccinated with his first dose of ZOSTAVAX (strength, dosage, frequency and route unspecified) and the second injection was administered on 28-OCT-2015 (extra dose administered). No adverse effects were reported. Additional information has been requested.
High fever, nausea, dizziness, fatigue, sore throat, headache Symptoms lasted 2 days Sore throat and fatigue lasted 5 days
Breakthrough case admission after three vaccines Moderna 1/23/21 NO LOT#;  Moderna 2/23/21 Lot# 027L20A;  Moderna 11/23/21 Lot# 077C21B
Pain at injection site, fingers felt numb and tingly, difficulty concentration, felt warm/burning (probably had fever), felt weak, dizzy, heart rate speeding up. Even today have difficulty concentrating.
first dose /on 28-Oct-2019 /has not received dose two.; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 28th October 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up via fax.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 34-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 34 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Ulcerative Colitis" (unspecified if ongoing); "Endometriosis" (unspecified if ongoing); "shellfish" (unspecified if ongoing). Concomitant medication(s) included: REMICADE. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown Results; (03May2022) Negative; (07Jun2022) Positive. Therapeutic measures were taken as a result of covid-19.  Clinical course: The patient received Paxlovid for COVID-19 from 26May2022 to 30May2022. Took a COVID test on 03May2022 which was negative. Started having a sore throat on 06Jun222, Sore throat and congestion on 07Jun2022 and had positive rapid and PCR test.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2 to the drug ineffective and Covid 19 cannot be ruled out.
Information has been received from a health professional concerning a male patient with food allergy to "tuna" who on 18-JUN-2007 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy included poliovirus vaccine and diphtheria toxoid/tetanus toxoid on same day. The reporter reported that the patient experienced fever, chills, sterile abscess, swelling in area of vaccine and cellulitis for which emergency room visit was required. It was reported that several days later on an unspecified day patient recovered. Additional information has been requested.
"Moderna COVI-19 Vaccine EUA" Patient received 0.5ml instead of 0.25ml COVID booster dose.
pain in the ear; This spontaneous case was reported by an other health care professional and describes the occurrence of EAR PAIN (pain in the ear) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EAR PAIN (pain in the ear). At the time of the report, EAR PAIN (pain in the ear) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not reported.
Felt a little disconnected about 30 minutes after shot. About 6:00 PM I started having problems breathing and started coughing. From there my eyes starting burning and turned ready and my face got puffy and my throat started to swell. Went to emergency room and the local hospital where they started an IV and gave me Cortisone, Benadryl and Pepcid. Gave me a prescription for Pepcid and Benadryl for at home. Went home after a few hours at the emergency room at my local hospital.
A non-serious spontaneous report of FLUMIST administered to a nine-year-old with diabetes was received from a physician concerning a nine-year-old female. Medical history included diabetes. No concomitant medications have been reported for this patient. On 02-Nov-2011, a nine-year-old female with diabetes received FLUMIST (LAIV) instead of TIV. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
After five minutes in the observation area, the patient abruptly stood up and began to walk across sales floor, but became light headed, laid on the ground, and bumped her head.  Her parents assisted to her first, pharmacist provided ice pack to head, and called 911. She experienced slight bump of inflammation  on upper right forehead. I paged primary care provider as well. The physician on call stated she would call the family and also follow up again with parents on 12/20/21.  The patient went to ER. I followed up with mother, at 7:53pm who stated doctor checked her heart rate and oxygen levels. She is fine and she is home resting, mainly was a vasovagal syncope episode.
Arm Pain; There is small bumps and now there is like larger rash all over my face and scalp/rash on the face; This is a spontaneous report from a contactable consumer or other non hcp (Patient herself) via medical information team. A 21-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number was not reported, Expiry date: 31Jul2021) via an unspecified route of administration, administered in Arm Left on 07May2021 (at the age of 21-years-old) as dose 1, single for COVID-19 immunization. Medical history included Birth control like a Contraceptives from an unknown date and ongoing. Concomitant medication(s) included ethinylestradiol, norethisterone acetate (LOESTRIN) taken for contraception, start and stop date were not reported. On 10May2021 the patient got vaccine on Friday, and she notice symptoms when she woke up on Monday, she doesn't know it was 36 hours or more than that she guess like two and half day after that she got it Friday afternoon. the symptoms are persisting and actually got worse because first there is small bumps and now there is like larger rash all over my face and scalp and on unspecified date patient experienced arm pain. Patient just called to report the symptom that she had and called because she was not sure if she should get the second dose or if she should take a different vaccine. Therapeutic measures were taken which includes Ibuprofen for arm pain. The outcome of event there is small bumps and now there is like larger rash all over my face and scalp/rash on the face was not recovered and the outcome of arm pain was unknown.     No follow-up attempts are needed; information about lot/batch number cannot be obtained.
p/vax pt exp shingles w/a dermatomal rash along C5-C6 on the arm;
On 07/27/2001 the patient developed a local reaction at the injection site. The reaction lasted more than 48 hours. The patient complained of pain, tenderness, swelling and redness. The area of reaction was more than 3 inches.